BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 19703659)

  • 21. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.
    Dei R; Takeda A; Niwa H; Li M; Nakagomi Y; Watanabe M; Inagaki T; Washimi Y; Yasuda Y; Horie K; Miyata T; Sobue G
    Acta Neuropathol; 2002 Aug; 104(2):113-22. PubMed ID: 12111353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA repair in neurons: so if they don't divide what's to repair?
    Fishel ML; Vasko MR; Kelley MR
    Mutat Res; 2007 Jan; 614(1-2):24-36. PubMed ID: 16879837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunopathogenic role of reactive oxygen species in Alzheimer disease.
    Mohsenzadegan M; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2012 Sep; 11(3):203-16. PubMed ID: 22947905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain.
    Raukas M; Rebane R; Mahlapuu R; Jefremov V; Zilmer K; Karelson E; Bogdanovic N; Zilmer M
    Free Radic Res; 2012 Dec; 46(12):1490-5. PubMed ID: 22962855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.
    Michel TM; Gsell W; Käsbauer L; Tatschner T; Sheldrick AJ; Neuner I; Schneider F; Grünblatt E; Riederer P
    J Alzheimers Dis; 2010; 19(4):1295-301. PubMed ID: 20061610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease.
    Moreira PI; Zhu X; Lee HG; Honda K; Smith MA; Perry G
    Mech Ageing Dev; 2006 Jun; 127(6):501-6. PubMed ID: 16516950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial aging and dysfunction in Alzheimer's disease.
    Sullivan PG; Brown MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):407-10. PubMed ID: 15795049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is the lesion produced by oxidation a central part in the pathogenesis of Alzheimer's disease?].
    Perry G; Smith MA
    Neurologia; 1999 Feb; 14(2):78-84. PubMed ID: 10100423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
    Singh M; Dang TN; Arseneault M; Ramassamy C
    J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.
    Castellani RJ; Honda K; Zhu X; Cash AD; Nunomura A; Perry G; Smith MA
    Ageing Res Rev; 2004 Jul; 3(3):319-26. PubMed ID: 15231239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain.
    Korolainen MA; Goldsteins G; Nyman TA; Alafuzoff I; Koistinaho J; Pirttilä T
    Neurobiol Aging; 2006 Jan; 27(1):42-53. PubMed ID: 16298240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress signalling in Alzheimer's disease.
    Zhu X; Raina AK; Lee HG; Casadesus G; Smith MA; Perry G
    Brain Res; 2004 Mar; 1000(1-2):32-9. PubMed ID: 15053949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular and cardiovascular pathology in Alzheimer's disease.
    de la Torre JC
    Int Rev Neurobiol; 2009; 84():35-48. PubMed ID: 19501712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleic acid oxidation in Alzheimer disease.
    Moreira PI; Nunomura A; Nakamura M; Takeda A; Shenk JC; Aliev G; Smith MA; Perry G
    Free Radic Biol Med; 2008 Apr; 44(8):1493-505. PubMed ID: 18258207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows.
    Praticò D
    Ann N Y Acad Sci; 2008 Dec; 1147():70-8. PubMed ID: 19076432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial dysfunction in rat brain with aging Involvement of complex I, reactive oxygen species and cardiolipin.
    Petrosillo G; Matera M; Casanova G; Ruggiero FM; Paradies G
    Neurochem Int; 2008 Nov; 53(5):126-31. PubMed ID: 18657582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease.
    Moreira PI; Duarte AI; Santos MS; Rego AC; Oliveira CR
    J Alzheimers Dis; 2009; 16(4):741-61. PubMed ID: 19387110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses].
    Zádori D; Datki Z; Penke B
    Ideggyogy Sz; 2007 Nov; 60(11-12):428-37. PubMed ID: 18198789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.